• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    More On ACR.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Acrux Limited (ACR.AX)

    -ASX
    0.63 Down 0.02(3.08%) 12:10AM EST
    Prev Close:0.65
    Open:0.65
    Bid:0.63
    Ask:0.64
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.63 - 0.65
    52wk Range:0.56 - 1.50
    Volume:231,641
    Avg Vol (3m):172,187
    Market Cap:104.91M
    P/E (ttm):9.40
    EPS (ttm):0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Headlines

    • No Headlines available for ACR.AX at this time.

    Key Statistics

    Forward P/E (1 yr):7.88
    P/S (ttm):4.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :0.08
    Quarterly EPS Est (Dec-15) :N/A
    Mean Recommendation*:3.8
    PEG Ratio (5 yr expected):-0.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acrux Limited develops and commercializes healthcare products in Australia, Switzerland, the United States, and internationally. It markets Axiron for the treatment of testosterone deficiency in men; Evamist for menopausal symptoms; and Recuvyra t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback